[go: up one dir, main page]

ATE22564T1 - O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen. - Google Patents

O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen.

Info

Publication number
ATE22564T1
ATE22564T1 AT84102005T AT84102005T ATE22564T1 AT E22564 T1 ATE22564 T1 AT E22564T1 AT 84102005 T AT84102005 T AT 84102005T AT 84102005 T AT84102005 T AT 84102005T AT E22564 T1 ATE22564 T1 AT E22564T1
Authority
AT
Austria
Prior art keywords
carbon atoms
residue
alkanediol
acyl
preparation
Prior art date
Application number
AT84102005T
Other languages
English (en)
Inventor
Hans-Heiner Dr Lautenschlaeger
Erich Dr Graf
Sigurd Dr Leyck
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of ATE22564T1 publication Critical patent/ATE22564T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18Polyhydroxylic acyclic alcohols
    • C07C31/20Dihydroxylic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT84102005T 1983-03-05 1984-02-25 O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen. ATE22564T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833307925 DE3307925A1 (de) 1983-03-05 1983-03-05 Neue 0-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP84102005A EP0121088B1 (de) 1983-03-05 1984-02-25 O-Acyl-Alkandiol-Phospholipide, Verfahren zu ihrer Herstellung und sie enthaltende pharmateutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE22564T1 true ATE22564T1 (de) 1986-10-15

Family

ID=6192681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84102005T ATE22564T1 (de) 1983-03-05 1984-02-25 O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4610979A (de)
EP (1) EP0121088B1 (de)
JP (1) JPS59170097A (de)
AT (1) ATE22564T1 (de)
DE (2) DE3307925A1 (de)
ZA (1) ZA841533B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3662197D1 (en) * 1985-07-15 1989-04-06 Takeda Chemical Industries Ltd 2-alkanoyloxypropane derivatives, their production and use
IE59664B1 (en) * 1985-12-04 1994-03-09 Max Planck Gesellschaft Phosphorus-containing organic compounds, process for the preparation thereof and medicaments containing them
US5185334A (en) * 1989-07-31 1993-02-09 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
JP2512019Y2 (ja) * 1991-01-31 1996-09-25 三菱重工業株式会社 容器洗浄装置
DE4234130A1 (de) * 1992-10-09 1994-04-14 Max Planck Gesellschaft Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen
GB9301702D0 (en) * 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
IL156015A0 (en) * 2000-11-24 2003-12-23 Vascular Biogenics Ltd Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
CN101570764A (zh) 2001-10-19 2009-11-04 脉管生物生长有限公司 多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
US7807847B2 (en) 2004-07-09 2010-10-05 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
KR100951108B1 (ko) 2008-04-15 2010-04-07 엔자이텍 주식회사 라세믹 또는 광학적으로 활성이 있는 α-글리세로포스포릴콜린 및 그 유도체의 제조방법
AU2009312355C1 (en) 2008-11-06 2016-02-18 Vascular Biogenics Ltd. Oxidized lipid compounds and uses thereof
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
JP6717825B2 (ja) 2014-11-26 2020-07-08 バスキュラー バイオジェニックス リミテッド 酸化脂質、および線維症の処置または予防方法
ES2739773B2 (es) * 2018-08-02 2020-11-17 Univ Alicante Compuestos zwitterionicos de acidos 2-fosfocolina carboxilicos y su uso como agentes citotoxicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542820A (en) * 1968-10-08 1970-11-24 American Home Prod Alpha,omega - alkanediolphosphorylalkanolamine derivatives and process for preparing thereof
DE2345057C3 (de) * 1973-09-06 1982-05-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur Herstellung von Propandiol (1,3)-phosphatiden
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
US4493832A (en) * 1981-07-03 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same

Also Published As

Publication number Publication date
US4610979A (en) 1986-09-09
DE3307925A1 (de) 1984-09-06
ZA841533B (en) 1984-10-31
EP0121088B1 (de) 1986-10-01
DE3460843D1 (en) 1986-11-06
JPS59170097A (ja) 1984-09-26
EP0121088A1 (de) 1984-10-10

Similar Documents

Publication Publication Date Title
ATE22564T1 (de) O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen.
ATE18910T1 (de) Succinimid-derivate und verfahren zu ihrer herstellung.
ATE78259T1 (de) 9-(phosphonylmethoxyalkyl)-adenine, verfahren zu ihrer herstellung und ihre verwendung.
IE791565L (en) Crop cutting apparatus
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
ES483511A1 (es) Un procedimiento para la preparaion de nuevas espiro-oxazo- lidinohoinas.
DE122009000040I1 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE19066T1 (de) 1,3-dihydro 4-(1-hydroxy-2-aminoethyl)2-h-indol-2-on-deriva e, ihre saelze, verfahren zu ihrer herstellung, verwendung als heilmittel und zusammenstellungen die sie enthalten.
MD422C2 (ro) Derivaţi ai azolului şi compuţi intermediari pentru producerea lor
SE8306370D0 (sv) Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
ES484553A1 (es) Un metodo para preparar 4-fenil-1,3-benzodiazepinas
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE72247T1 (de) Estran- und androstan-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende praeparate.
ES8304916A1 (es) Procedimiento para preparar esteres de 2-nitro-5(fenoxi sus-tituido-benzoato de alfa-hidroxialcanoatos)
ATE8257T1 (de) Verfahren zur herstellung von 4-chinolinonen.
NZ189091A (en) Prostaglandin derivatives
AU539348B2 (en) 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
ATE36321T1 (de) (bis(substituiertes methyl)methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ES481418A1 (es) Un procedimiento para preparar un compuesto de 5,8-dihidro- furo 3,2-b, 1,8-naftiridina
ES8405797A1 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE18223T1 (de) Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1508330A (en) 2-stilbenyl-1,2,3-triazoles and their use as optical brightening agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee